FY2015 Semi-Annual Performance Report: Control and Prevention Tuberculosis Project

The project's primary objective is to scale up its model for controlling tuberculosis (TB) and multi-drug resistant tuberculosis (MDR-TB) with a focus on long-term sustainability. The CAP-TB model is patient-centered and community-driven, aiming to strengthen TB platforms by identifying gaps in the system and addressing them through targeted interventions. The model prioritizes community-driven solutions, cost-effectiveness, and capacity-building at the grassroots level. In China, the project has scaled up to rural Yunnan Province, adapting the urban model to address the high number of TB cases in the province. In Thailand, the project has been requested by the Ministry of Public Health to provide technical support in Kanchanaburi Province, which has the largest MDR-TB outbreak. In Burma, the CAP-TB scale-up, funded by the Three Millennium Development Goals (3MDG) Fund, will standardize support for nearly 1800 MDR-TB patients in the highest MDR-TB prevalent townships in Yangon. The project's patient-centered, community-driven model is now led by the Myanmar National Tuberculosis Program (NTP) and implemented by local organizations that have partnered with CAP-TB. Sustainability and cost-share are critical priorities for the project, particularly in Burma, where the CAP-TB model scale-up by 3MDG demonstrates strong support and recognition from the NTP. The longer-term goal is for the Burma government to support MDR-TB patients from diagnosis through treatment, ensuring cost-effectiveness for the project's implementation. In China, the project has received financial support in the form of cost-share from the government to conduct its activities. The CAP-TB project will continue to prioritize data analysis and interpretation to measure its impact on case detection and treatment outcomes. The project's interventions aim to impact prevention, diagnosis, and treatment, with a focus on minimizing transmission among household and community contacts, measuring the efficiency of identifying presumptive patients, and initiating treatment for all patients who are diagnosed. In Burma, the project has achieved significant results in TB patient registration, TB prevention and treatment messages, and referrals to TB- and MDR-TB related services. In China, the project has scaled up to rural Yunnan Province and has received financial support in the form of cost-share from the government. The project's data analysis and interpretation will continue to be a priority to measure its impact on case detection and treatment outcomes. The CAP-TB project has also published a manuscript on screening patients with Diabetes Mellitus for Tuberculosis in community health settings in China, in partnership with The Union. The project has submitted six abstracts analyzing data from the CAP-TB project to the Union's 46th World Lung Conference in Cape Town.